Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.
about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesTransforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasisTransforming growth factors-beta are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system.Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-betaInduction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitroSheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionTGF-β - an excellent servant but a bad masterDoxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse modelsCell cycle related proteins in hyperplasia of usual type in breast specimens of patients with and without breast cancer.Smad4-expression is decreased in breast cancer tissues: a retrospective study.Differential expression of TGF-beta isoforms during differentiation of HaCaT human keratinocyte cells: implication for the separate role in epidermal differentiation.The roles of TGFβ in the tumour microenvironment.An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancerOestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.Spotlight on differentially expressed genes in urinary bladder cancer.Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.Roles for growth factors in cancer progression.Transforming growth factor-β and the hallmarks of cancer.Loss of Dab2 expression in breast cancer cells impairs their ability to deplete TGF-β and induce Tregs development via TGF-β.HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.The type III TGF-beta receptor suppresses breast cancer progressionTransforming growth factor Beta leucine10 proline variation and breast cancer risk in Iranian women.p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.Melanoma-associated expression of transforming growth factor-beta isoformsTumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathwaysRole of TGF-beta 1 and TGF-beta type II receptor in gastric cancer.Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma.Expression of transforming growth factor beta mRNA isoforms in human breast cancerTGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinomap21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapyTransforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.
P2860
Q24551158-0D9126A6-7DEE-44C4-828A-B579726535D7Q24679619-C6E8BE96-C2BB-4C86-8AEB-F6A9FBC5A8F5Q24791032-7B0C056E-E475-4EA1-A8A5-C4B61370D138Q24793319-6E351349-B476-41B3-B355-F664FDC80AF2Q24794867-DA6D3891-C122-4E3E-994A-66C4EABC0D10Q26864979-88865DB0-5042-425C-AAAD-96EA2468B1C4Q27025590-4C281ABF-626D-4536-AFB8-83D6666B726AQ28473783-15C8E4A3-19C3-43F8-AB79-217EC16C60B1Q30820696-5772C594-FD43-4FF7-B59E-3E215767D0DCQ33232550-D6FADA88-8B7C-4BC3-8698-64182E94334EQ33629520-8BE4A9F3-7045-492F-92EF-8F20AF96A0D6Q33630845-B1F5A8FF-3EAB-4753-BB1B-E08B340F1498Q33812340-F159B294-C186-40F0-A4AB-2651BD1B4540Q33842800-399443D8-02A6-4D02-8EA2-3C9A920FBE1BQ33869194-D41FBFE8-4AE4-45E7-8621-595851E54357Q33933880-7946DC2C-7AAB-49A4-A4B3-1E3093078766Q34157940-89497B4C-AD76-4491-9B81-1DBE08BA7CFDQ34358613-E57D5ED5-BD77-4332-9F1D-BBC07336DEC8Q34705858-D5815CFC-BB5C-4F5F-B818-A44C26FCA2EFQ34789300-ECCDD969-B47D-465E-9111-4F00373556B7Q35123215-916FCD4C-EECC-4E79-9848-2B936A560DBAQ35155602-3AB6AD49-0835-44E5-9900-ECEF3C8E284DQ35191593-3FCAAB42-FF3E-471C-A42E-6332BE1C7E1BQ35474915-AC4E5416-3E8E-498E-A80D-7D9CA6D984D6Q35586711-64E65A98-618B-47F4-84A1-8BCEEB6476F2Q35613285-5836F547-AB78-4B3A-B82E-7F80940E26D7Q35628188-C2DBE4C2-F4DC-4306-8161-D37D4083B110Q35764623-EE620F5D-DF29-46DD-BB40-58AAE8F273DCQ35773856-68274361-4137-4872-8AE9-B186F291D895Q35773976-F353C064-0E6D-461C-AED6-5E5AB9C8AAFDQ35787792-FBA1A870-257C-4EFB-9772-6C98265F06FDQ35930474-DB8941F0-A3F6-42F0-9E50-ADB5C7381CBDQ35937392-62B331BB-A481-416E-9187-4E6153FDD06EQ35979144-9FC1E4BB-F2E5-45CF-8485-0F9E5087B53FQ35979175-6A4BF1A3-4487-4B30-8736-4336490A8300Q36001319-4CD66F20-5823-469D-A430-31C8B06FFB72Q36115650-0056B2B0-FE5F-4F4D-BD88-3128598F0585Q36135459-D863BA8F-C485-4AC3-BE1F-4B67FCF97CE8Q36135815-963B53ED-C364-44AB-9A73-5A7234142E5BQ36135981-45157C13-4628-4626-9D66-B2C6451CB2C4
P2860
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Immunohistochemical staining f ...... ession in human breast cancer.
@ast
Immunohistochemical staining f ...... ession in human breast cancer.
@en
type
label
Immunohistochemical staining f ...... ession in human breast cancer.
@ast
Immunohistochemical staining f ...... ession in human breast cancer.
@en
prefLabel
Immunohistochemical staining f ...... ession in human breast cancer.
@ast
Immunohistochemical staining f ...... ession in human breast cancer.
@en
P2093
P1433
P1476
Immunohistochemical staining f ...... ession in human breast cancer.
@en
P2093
P304
P407
P577
1992-12-01T00:00:00Z